Nearly 5.3 million Americans are living with Alzheimer's disease, and 26.6 million people are affected worldwide. The Alzheimer's Disease Neuroimaging Initiative (ADNI), a public-private partnership, provides a publicly available, international database of clinical and imaging data to foster research and collaboration on Alzheimer's research worldwide. The Institute of Medicine held a workshop on July 12, 2010, to explore opportunities to use information from and partnerships formed because of ADNI to continue to improve the understanding and treatment of Alzheimer's disease.
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Sciences Policy, African Science Academy Development Initiative, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Patricia A. Cuff, Theresa M. Wizemann, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Theresa Wizemann, Diana E. Pankevich
National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Institute of Medicine, Board on Health Sciences Policy, Committee on the Use of Chimpanzees in Biomedical and Behavioral Research, Jeffrey P. Kahn, Marilee K. Shelton-Davenport, Diana E. Pankevich, Bruce M. Altevogt
National Research Council, Institute of Medicine, Division on Earth and Life Studies, Institute for Laboratory Animal Research, Policy and Global Affairs, and Law Committee on Science, Technology, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Bruce M. Altevogt, Anne-Marie Mazza, Theresa M. Wizemann, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous Systems Disorders, Bruce M. Altevogt, Theresa Wizemann, Diana E. Pankevich
Institute of Medicine, Board on Health Sciences Policy, Forum on Neuroscience and Nervous System Disorders, Sheena M. Posey Norris, Diana E. Pankevich, Miriam Davis, Bruce M. Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, and Translation Forum on Drug Discovery, Development, Anne B. Claiborne, Bruce M. Altevogt, Theresa Wizemann
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Theresa Wizemann, Clare Stroud, Bruce M. Altevogt
Institute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Theresa Wizemann, Kristin Viswanathan
Institute of Medicine, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Forum on Medical and Public Health Preparedness for Catastrophic Events, Bruce M. Altevogt, Clare Stroud, Theresa Wizemann